GlucoTrack, Inc. Announces Board Changes and Fiscal Year Update

Ticker: GCTK · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateJun 20, 2024
Risk Levelmedium
Pages3
Reading Time4 min
Sentimentneutral

Sentiment: neutral

Topics: governance, board-changes, bylaws, fiscal-year

TL;DR

GlucoTrack's board is changing, new officers appointed, and fiscal year shifted. Big governance moves.

AI Summary

GlucoTrack, Inc. announced on June 14, 2024, a change in its board of directors, with the election of new directors and the appointment of certain officers. The company also disclosed compensatory arrangements for these officers. Additionally, GlucoTrack filed an 8-K to report amendments to its articles of incorporation or bylaws and a change in its fiscal year.

Why It Matters

Changes in board composition and officer appointments can signal shifts in company strategy or governance, while a fiscal year change may impact financial reporting and investor analysis.

Risk Assessment

Risk Level: medium — Board and officer changes, along with amendments to corporate documents, can introduce uncertainty regarding future strategy and operations.

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates the election of directors and appointment of certain officers, but does not specify the names of the individuals or the exact nature of the changes in this excerpt.

Were there any changes to the company's bylaws or articles of incorporation?

Yes, the filing explicitly states that amendments to the articles of incorporation or bylaws are being reported.

Has GlucoTrack, Inc. changed its fiscal year end?

Yes, the filing indicates a change in the company's fiscal year.

What is the company's current fiscal year end?

The filing mentions a fiscal year end of 1231, but the specific year is not detailed in this excerpt.

What is the SEC file number for GlucoTrack, Inc.?

The SEC file number for GlucoTrack, Inc. is 001-41141.

Filing Stats: 1,049 words · 4 min read · ~3 pages · Grade level 12.4 · Accepted 2024-06-20 08:30:40

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 20, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing